Month: January 2026

Experienced medical executive advances to permanent role following successful leadership as Interim CMO SEATTLE and VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of nicotine dependence for smoking cessation, today announced that it has confirmed the promotion of Mark Rubinstein, M.D., from Interim Chief Medical Officer to Chief Medical Officer (CMO). Since Dr. Rubinstein began his tenure as Interim CMO in September 2025, the company has achieved significant clinical and regulatory milestones, and he co-authored the recent paper in Thorax of data demonstrating cytisinicline’s potential efficacy and tolerability for smoking cessation in individuals...

Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomes SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) — Counterpart Health, Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research demonstrating the platform’s impact on chronic disease management, meaningful product expansion, and the scaled adoption of Counterpart Assistant (CA) by hundreds of live third-party customer clinicians across diverse practice settings. Clinical Quality and Financial Performance Outcomes Data released in 2025 highlights the scale...

SANTA ANA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology products, including mission systems, radio frequency (“RF”) components, RF microwave/microelectronic assemblies, and technologically advanced printed circuit boards (“PCB”s), is proud to announce that its Syracuse Campus has been named the winner of the fifth annual TTM Chair for Community Service Award. This significant honor recognizes the Syracuse Campus teams across two locations for their exceptional and heartfelt contributions to the Central New York community throughout 2025. As part of the award, TTM will donate $20,000 to the United Way of Central New York. The Syracuse Campus has maintained a long-standing partnership with the United Way of Central New York (“CNY”). In 2025, two...

BOCA RATON, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) — NewtekOne, Inc. (the “Company”) (NASDAQ: NEWT) will report its fourth quarter 2025 financial results after the market closes on Thursday, January 29, 2026. A conference call to discuss these results will be hosted by Barry Sloane, Chief Executive Officer, and Frank DeMaria, Chief Financial Officer, at 4:30 pm ET on Thursday, January 29, 2026. Please note, to receive a dial-in number for the conference call or to listen to the webcast, interested participants are encouraged to pre-register online at NewtekOne Fourth Quarter 2025 Financial Results beginning today and up until 15 minutes prior to the start of the January 29, 2026 conference call in order to reserve a listening position on the call. Concurrent with the release of 4Q25 financial results, a corresponding earnings presentation...

Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year 2026 guidance range. Reaffirms its full-year 2025 guidance ranges on health plan membership, revenue, adjusted gross profit and adjusted EBITDA.ORANGE, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), an award-winning Medicare Advantage (MA) company, today announced Jan. 1 health plan membership of approximately 275,300, representing 31% year-over-year growth following a strong annual enrollment period (AEP). Since its IPO in 2021, the company has achieved a compounded annual membership growth rate of approximately 30%, underscoring sustained performance in the MA market. Following its AEP results,...

VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company“) (TSXV: LMS) (OTCQB: LMSQF) is pleased to provide shareholders with an overview of project advancement achieved during 2025 and the exploration and corporate activities planned for 2026, as the Company transitions from project advancement to execution, with multiple drill-ready assets across its gold and copper portfolio. Following a year focused on drill permitting, project expansions, and the advancement of partner-funded exploration agreements, Latin Metals enters 2026 with several drill-ready projects and active partner-funded exploration programs, supported by a strengthened balance sheet and no near-term requirement for equity financing. Keith Henderson, President & CEO of Latin Metals,...

Achieves Target Goal of 17 Million Shares Outstanding Roseville, Minnesota, Jan. 12, 2026 (GLOBE NEWSWIRE) — SecureTech Innovations, Inc. (OTC: SCTH), a pioneering technology company advancing artificial intelligence, industrial 3D printing and manufacturing technologies, cybersecurity, and digital infrastructure solutions, is excited to announce the successful completion of its Share Reduction Program launched in early 2025. The program was carried out in three phases:Phase 1: 43,100,000 shares of common stock were canceled, reducing the total share count by approximately 55%. Phase 2: Another 4,000,000 shares were canceled. Final Phase: 14,300,000 more shares were canceled, reducing the total number of issued and outstanding shares by an additional 46%.Following the completion of all phases, SecureTech now has 17,077,368...

New Joint Venture Creates a Strategic Operating Platform Seeking to Expand VisionWave’s Intellectual Property Footprint and Execution Capabilities WEST HOLLYWOOD, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV), a defense technology and advanced systems company focused on secure architectures, artificial intelligence, autonomous operations, and computational acceleration, announced today the formation of a strategic joint venture platform designed seeking to expand VisionWave’s intellectual property and technology execution capabilities. This joint venture (the “JV LLC”), to be formed as a Nevada limited liability company, represents a pivotal strategic milestone for VisionWave — creating a dedicated operating platform with the goal of accelerating the development, integration, and commercialization...

Findings Show Xenon MRI Ventilation Defects Independently Predicts Exacerbation Risk Beyond Conventional Clinical MeasuresNew CHEST Journal Study Demonstrates Xenon MRI Predicts Cystic Fibrosis ExacerbationsFindings Show Xenon MRI Ventilation Defects Independently Predicts Exacerbation Risk Beyond Conventional Clinical MeasuresDURHAM, NC and London, Jan. 12, 2026 (GLOBE NEWSWIRE) — Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, today highlighted the publication of a peer-reviewed clinical study in CHEST. The study demonstrates that structural and functional pulmonary MRI adds important new insights in predicting pulmonary exacerbations beyond standard pulmonary function tests in people living with cystic fibrosis (CF). The study, titled “Structural and Functional Pulmonary...